51st week of 2010 patent applcation highlights part 51 |
Patent application number | Title | Published |
20100324100 | SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS - A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases. | 2010-12-23 |
20100324101 | Use of Succinate Dehydrogenase Inhibitors for Increasing the Resistance of Plants or Parts of Plants to Abiotic Stress - The invention relates to the use of succinate dehydrogenase inhibitors, in particular bixafen, for increasing the resistance of plants to abiotic stress factors, to a method for treating plants or parts of plants for increasing the resistance to abiotic stress factors and to a method for increasing the resistance of seed and germinating plants to abiotic stress factors by treating the seed with a succinate dehydrogenase inhibitor. | 2010-12-23 |
20100324102 | N-(3-PYRIDIN-2-YLPROPYL) BENZAMIDE DERIVATIVES AS FUNGICIDES - A compound of general formula (I) | 2010-12-23 |
20100324103 | Substituted Enaminocarbonyl Compounds - The present application relates to substituted enaminocarbonyl compounds of the formula (I) | 2010-12-23 |
20100324104 | 1,2,3-TRIAZOLES AS 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS - Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds of formula (I): or stereoisomers or pharmaceutically acceptable salts thereof, wherein R | 2010-12-23 |
20100324105 | Methods of Reducing Serum Glucose and Triglyceride Levels and for Inhibiting Angiogenesis Using Substituted Indolealkanoic Acids - Disclosed are methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds. | 2010-12-23 |
20100324106 | COMPOUNDS - The present invention relates to novel indole derivatives having pharmacological activity, processes for their preparation, compositions containing them and the use of these compounds in the treatment of estrogen receptor beta mediated diseases. | 2010-12-23 |
20100324107 | USE OF PHTHALIMIDE AND/OR SULPHONAMIDE DERIVATIVES IN THE TREATMENT OF DISEASES WHICH REQUIRE REDUCING THE TNF-alpha LEVELS AND AN EXOGENOUS SOURCE OF NITRIC OXIDE, PHTHALIMIDE DERIVATIVES, SULPHONAMIDE DERIVATIVES, AND A METHOD FOR OBTAINING A SULPHONAMIDE DERIVATIVE - The present invention refers to the use of phthalimide and/or sulphonamide derivatives with nitric oxide donor properties, which have important activities in increasing the gamma-globin gene expression and anti-inflammatory and analgesic activities, effective in the treatment of hematologic diseases which require reducing the TNF-α levels and an exogenous source of nitric oxide. More particularly, the present invention describes the use of such phthalimide and/or sulphonamide derivatives for the treatment of sickle-cell disease. The invention also has as a novel characteristic the disclosure of new functionalized phthalimide derivatives designed from the prototypes thalidomide and hydroxyurea, and designed rationally through the strategy of molecular hybridization for the treatment of said diseases. The invention still discloses a new method for obtaining a specific sulphonamide derivative which can be used in the preparation of a drug for the treatment of diseases which require reducing the levels of the TNF-α factor and an exogenous source of nitric oxide. | 2010-12-23 |
20100324108 | SUBSTITUTED ISOINDOLINE-1,3-DIONE DERIVATIVES - This invention relates to novel substituted isoindoline-1,3-dione derivatives and pharmaceutically acceptable salts thereof. More specifically, the invention relates to novel substituted isoindoline-1,3-dione derivatives that are analogues of apremilast. This invention also provides compositions comprising a compound of this invention and a carrier and the use of disclosed compounds and compositions in methods of treating diseases and conditions that are beneficially treated by administering apremilast. | 2010-12-23 |
20100324109 | Composition for Topical Use - The use, as a dermatological or cosmetic medicament, of compounds capable of transiently interacting with the AhR receptor (aryl hydrocarbon receptor) as agents for modulating skin functions such as sebaceous function, skin healing, skin atrophy termed “dermatoporosis”, estrogen deprivation and defense against infection, without inducing other toxic effects of the TCDD type. | 2010-12-23 |
20100324110 | Self Solidifying Bioerodible Barrier Implant - Provided are bioerodible compositions that can be implanted into cavities of mammalian tissue as a liquid or semi-liquid and which solidify upon exposure to body temperature of the mammal. The implants erode over a prescribed period of time and elute a drug. The implants also form a seal with the skin or mucosa surrounding the cavity to prevent the entry of bacterial pathogens. | 2010-12-23 |
20100324111 | COMBINATION COMPRISING PYRROLIDONE-5-CARBOXYLIC ACID AND AT LEAST ONE COMPOUND FROM CITRULLINE, ARGININE AND ASPRAGINE, AND USE THEREOF IN THE TRATMENT OF ATOPIC DERMATITIS - The present invention relates to a composition comprising, in a physiologically acceptable carrier, pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and asparagine, in racemic or isomer form, and salts thereof, for the preparation of a medicament for use in the treatment and/or prevention of atopic dermatitis. | 2010-12-23 |
20100324112 | Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer - The present invention relates to the discovery that, in human cancer, an 11q deletion of ATM together with an increase in ATR and CHEK1 expression correlates with resistance to ionizing radiation which could be overcome by inhibition of the ATR/CHEK1 pathway. It provides for methods of identifying patients unlikely to exhibit an adequate response to radiation therapy and/or chemotherapy who may benefit from ATR/CHEK1 pathway inhibition, as well as methods of treating said patients. | 2010-12-23 |
20100324113 | Delivery Method - The present invention relates, in general, to siRNA and, in particular, to a method of effecting targeted delivery of siRNAs and to compounds suitable for use in such a method. | 2010-12-23 |
20100324114 | Methods and kits to detect hereditary angioedema type III - The present invention relates to a method of diagnosing hereditary angioedema type III (HAE III) or a predisposition thereto in a subject being suspected of having developed or of having a predisposition to develop a hereditary angioedema type III or in a subject being suspected of being a carrier for hereditary angioedema type III, the method comprising determining in vitro from a biological sample of said subject the presence or absence of a disease-associated mutation in a nucleic acid molecule regulating the expression of or encoding coagulation factor XII; wherein the presence of such a mutation is indicative of a hereditary angioedema type III or a predisposition thereto. The present invention also relates to a method of diagnosing hereditary angioedema type III (HAE III) or a predisposition thereto in a subject being suspected of having developed or of having a predisposition to develop a hereditary angioedema type III or in a subject being suspected of being a carrier for hereditary angioedema type III, the method comprising assessing the presence, amount and/or activity of coagulation factor XII in said subject and including the steps of: (a) determining from a biological sample of said subject in vitro, the presence, amount and for activity of: (i) a (poly)peptide encoded by the coagulation factor XII gene; (ii) a substrate of the (poly)peptide of (i); or (iii) a (poly)peptide processed by the substrate mentioned in (ii); (b) comparing said presence, amount and/or activity with that determined from a reference sample; and (c) diagnosing, based on the difference between the samples compared in step (b), the pathological condition of a hereditary angioedema type III or a predisposition thereto. The present invention also relates to a method of identifying a compound modulating coagulation factor XII activity which is suitable as a medicament or a lead compound for a medicament for the treatment and/or prevention of hereditary angioedema type III, the method comprising the steps of: (a) in vitro contacting a coagulation factor XII (poly)peptide or a functionally related (poly)peptide with the potential modulator; and (b) testing for modulation of coagulation factor XII activity, wherein modulation of coagulation factor XII activity is indicative of a compound's suitability as a medicament for the treatment and/or prevention of hereditary angioedema type III. Furthermore, the present invention relates to gene therapy methods and to a kit for diagnosing hereditary angioedema type III. | 2010-12-23 |
20100324115 | Treatment of Squamous Cell Carcinoma with HSP27 Antisense Oligonucleotides and Radiotherapy - Squamous cell carcinomas, such as squamous head and neck cancer, are treated with a combination of radio-therapy and a therapeutic agent that reduces the amount of hsp27 in the squamous cancer cells. In specific embodiments, the therapeutic agent that reduces the amount of hsp27 is an antisense oligonucleotide therapeutic agent. | 2010-12-23 |
20100324116 | FAS/FASL OR OTHER DEATH RECEPTOR TARGETED METHODS AND COMPOSITIONS FOR KILLING TUMOR CELLS - Provided herein are methods and compositions for killing tumor cells. In certain embodiments, compositions can promote apoptosis by down-regulating FAPP2 and PATZ1 products. | 2010-12-23 |
20100324117 | HEPATITIS C DSRNA EFFECTOR MOLECULES, EXPRESSION CONSTRUCTS, COMPOSITIONS, AND METHODS OF USE - The present invention provides agents, compositions, constructs and methods for silencing HCV polynucleotides, as well as methods and compositions for treating or preventing HCV infection in a mammalian cell. In one aspect, the present invention provides an agent or composition comprising at least one double-stranded RNA effector molecule or complex. The double-stranded RNA effector molecule or complex comprises: (1) a sequence of at least 19 nucleotides having at least 90% identity with a nucleotide sequence within HCV Conserved Region 1 (SEQ ID NO: 2), HCV Conserved Region 2 (SEQ ID NO: 3), HCV Conserved Region 5 (SEQ ID NO: 4), (ATR)-1 (SEQ ID NO: 86), ATR-2 (SEQ ID NO: 87), ATR-3 (SEQ ID NO: 88), ATR-4 (SEQ ID NO: 89); and (2) its complementary sequence. In another aspect, the present invention provides a construct suitable for replication in a host cell, and/or suitable for expression of an RNA molecule or complex of the invention in vitro or in vivo. In a third aspect, the present invention provides a method for silencing HCV RNA in a mammalian cell, which comprises administering to the mammalian cell an agent, composition, or construct of the invention in a manner and amount effective to silence HCV RNA in the cell. In a related aspect, the invention provides a method for treating or preventing HCV infection in a patient, comprising administering to the patient an effective amount of an agent, composition, or construct of the invention as described herein. | 2010-12-23 |
20100324118 | Method for the Promotion of Angiogenesis, Vascularization, or Vascular Repair or for the Inhibition of Tumor Angiogenesis - The invention relates to a method for influencing the miR-92 expression in a cell, comprising the following steps: (a) providing a cell; and (b1) reducing the miR-92 expression in the cell in order to promote the vascularization or vessel repair by introducing an antisense molecule against miR-92 into the cell, or (b2) increasing the miR-92 expression in the cell for an inhibition of the tumor angiogenesis by introducing a construct into the cell, wherein said construct includes an expressible miR-92 sequence. Furthermore, the invention relates to a pharmaceutical composition, comprising an agent for reducing the miR-92 activity or expression in a cell in the form of an antisense molecule against miR-92, or an agent for increasing the miR-92 expression in a cell in the form of a construct for expressing miR-92. | 2010-12-23 |
20100324119 | REDUCING IRF4, DUSP22, OR FLJ43663 POLYPEPTIDE EXPRESSION - This document relates to the activity of interferon regulatory factor 4 (IRF4) in T-cell lymphomas. For example, methods and materials involved in reducing the expression of an IRF4 polypeptide in T-cell lymphoma cells and identifying agents having the ability to reduce expression of an IRF4 polypeptide in T-cell lymphoma cells are provided. This document also relates to reducing DUSP22 or FLJ43663 polypeptide activity in T-cell lymphomas. For example, methods and materials involved in reducing the expression of DUSP22 polypeptides and/or FLJ43663 polypeptides in T-cell lymphoma cells and identifying agents having the ability to reduce expression of DUSP22 polypeptides and/or FLJ43663 polypeptides in T-cell lymphoma cells are provided. | 2010-12-23 |
20100324120 | LIPID FORMULATION - The invention features a cationic lipid of formula I, | 2010-12-23 |
20100324121 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA - The invention provides compositions and methods for selectively reducing the expression of a gene product from a desired target gene, as well as treating diseases caused by expression of the gene. The method involves introducing into the environment of a cell an amount of a double-stranded RNA (dsRNA) such that a sufficient portion of the dsRNA can enter the cytoplasm of the cell to cause a reduction in the expression of the target gene. The dsRNA has a first oligonucleotide sequence that is between 26 and about 30 nucleotides in length and a second oligonucleotide sequence that anneals to the first sequence under biological conditions. In addition, a region of one of the sequences of the dsRNA having a sequence length of from about 19 to about 23 nucleotides is complementary to a nucleotide sequence of the RNA produced from the target gene. | 2010-12-23 |
20100324122 | MODULATION OF SGLT2 EXPRESSION - Compounds, compositions and methods are provided for modulating the expression of SGLT2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding SGLT2. Methods of using these compounds for modulation of SGLT2 expression and for diagnosis and treatment of diseases and conditions associated with expression of SGLT2 are provided. | 2010-12-23 |
20100324123 | GLMS RIBOSWITCHES, STRUCTURE-BASED COMPOUND DESIGN WITH GLMS RIBOSWITCHES, AND METHODS AND COMPOSITIONS FOR USE OF AND WITH GLMS RIBOSWITCHES - The glmS riboswitch is a target for antibiotics and other small molecule therapies. Compounds can be used to stimulate, active, inhibit and/or inactivate the glmS riboswitch. The atomic structures of the glmS riboswitch can be used to design new compounds to stimulate, active, inhibit and/or inactivate riboswitches. | 2010-12-23 |
20100324124 | Compositions and methods relating to DNA-based particles - The invention provides compositions and methods relating to delivery of agents in vivo or in vitro. More specifically, the invention provides nanoparticles synthesized from crosslinked nucleic acids, optionally having a lipid shell or coating, and may further comprise for example small molecule or high molecular weight compounds as therapeutic or diagnostic agents. | 2010-12-23 |
20100324125 | Proteins derived from white spot syndrome virus and uses thereof - Embodiments of the present invention generally relate to proteins derived from white spot syndrome virus, nucleic acid sequences encoding them, and their use in the manufacture of a vaccine for prophylaxis and/or treatment of white spot syndrome in crustaceans. | 2010-12-23 |
20100324126 | SYN3 COMPOSITIONS AND METHODS - Disclosed are aqueous and nonaqueous solution formulations containing agents that are useful for treating cancer. | 2010-12-23 |
20100324127 | TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN - The invention relates to methods and compositions for treating a neurodegenerative disease. More particularly, the present invention is directed to methods of treatment of neurodegenerative diseases using progranulin and progranulin polypeptides, and methods of treatment of neurodegenerative diseases using effectors, or combinations of effectors, that modify progranulin expression. | 2010-12-23 |
20100324128 | 9, 10-Alpha, Alpha-OH-Taxane Analogs and Methods for Production Thereof - The present invention relates to a method for the treatment of cancer in a cancer patient. In particular, the invention provides a method for the treatment comprising administering a taxane compound to a cancer patient, wherein the taxane compound is made by a process comprising treating a first compound represented by either Formula G′ or Formula M′: | 2010-12-23 |
20100324129 | ECTOPARASITICIDAL METHODS AND FORMULATIONS - Provided are novel methods and formulations for topically controlling ectoparasite infestations in animals using spinetoram or a pharmaceutically acceptable salt thereof. | 2010-12-23 |
20100324130 | DAA PERIPHERAL BENZODIAZEPINE RECEPTOR LIGAND FOR CANCER IMAGING AND TREATMENT - Peripheral Benzodiazepine Receptor (PBR) is an attractive target for tumor imaging and treatment due to its up-regulation in numerous cancer cell types. DAA1 106 is a selective PBR ligand with high binding affinity. Aspects of the present invention are series of functionalized DAA1 106 analogs, which can be conjugated to a variety of signaling and treatment moieties, and are widely applicable in PBR targeted molecular imaging and drug delivery. | 2010-12-23 |
20100324132 | METHODS AND COMPOSITIONS FOR PROMOTING WOUND HEALING - The present invention provides methods and compositions that use the combination of Tris and EDTA to inhibit the growth of microorganisms at the site of a wound or burn, and/or to promote the healing of a wound or burn, and/or to reduce the sensation of pain at the site of a wound or burn. The amount of Tris and EDTA applied to a wound or burn can be selected to achieve one or more of the foregoing effects. | 2010-12-23 |
20100324133 | Branched Diepoxide Compounds for the Treatment of Inflammatory Disorders - The present invention provides certain diepoxide carbocyclic compounds wherein at least one carbocyclic ring carbon includes two non-epoxide substituents, and pharmaceutical compositions containing the same, for the treatment or prophylaxis of inflammatory, autoimmune and hyper- or abnormally proliferative diseases and disorders. | 2010-12-23 |
20100324134 | MEDICAMENT FOR PREVENTIVE AND/OR THERAPEUTIC TREATMENT OF BOWEL DISEASE - A medicament for preventive and/or therapeutic treatment of a bowel diseases such as inflammatory bowel diseases including Crohn's disease, which comprises as an active ingredient a retinoid such as, for example, 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]benzoic acid. | 2010-12-23 |
20100324135 | DISINFECTANT AND METHOD OF MAKING - A non-toxic environmentally friendly aqueous disinfectant is disclosed for specific use as prevention against contamination by potentially pathogenic bacteria and virus. The aqueous disinfectant is formulated by electrolytically generating silver ions in water in combination with a citric acid. The aqueous disinfectant may include a suitable alcohol and/or a detergent. The aqueous disinfectant has been shown to be very effective at eliminating standard indicator organisms such as | 2010-12-23 |
20100324136 | Oily base for a cosmetic and cosmetic comprising the same - The present invention provides an oily base for a cosmetic comprising an ester compound made from a multivalent alcohol and a fatty acid, characterized in that the ester compound is made from pentaerythritol and isononanoic acid and a molar ratio of a pentaerythritol residue and an isononanoic acid residue in the ester compound is 1.0:2.3 to 1.0:4.0. The oily base for a cosmetic of the present invention has proper oily feeling with moistness, no sticky feeling, excellent adhesion to the skin and safety to the skin, and excellent compatibility with oil agents, among others, silicone oil. Furthermore, upon blending the present oily base in a cosmetic, besides having proper emollient property and moisturizing property, the cosmetic exhibits smooth feeling on use, excellent adhesion to the skin and safety to the skin, excellent cosmetic effect-holding ability, and storage stability. | 2010-12-23 |
20100324137 | LAURIC ARGINATE AS A CONTACT ANTIMICROBIAL - A surface disinfecting composition includes a combination of lauric arginate ethyl ester in combination with EDTA, octenyl succinic acid, octanoic acid, glycolic acid, lactic acid, or combinations thereof. The aqueous solution can be used to disinfect a wide variety of surfaces including food processing and storage equipment, vegetables and fruits, as well as animal carcasses such as poultry. | 2010-12-23 |
20100324138 | Lipoxin A4 Protection for Retinal Cells - Lipoxin A4 and its analogs have been found to be effective in inhibiting apoptosis of retinal pigment epithelial cells induced by oxidative stress. Thus lipoxin A4 and its analogs, for example, lipoxin A4 epimer 15, can be used to prevent and treat retinal diseases due to the progressive degeneration of photoreceptors and retinal pigment epithelial cells (RPE cells), e.g., the dry form of age-related macula degeneration. They can also be combined with other compounds known to prevent apoptosis in retinal pigment epithelial cells, e.g., docosahexaenoic acid and neuroprotectin D1. | 2010-12-23 |
20100324139 | PROCESS TO PREGABALIN - The present invention relates to a novel method for the preparation of racemic pregabalin (1) or a single enantiomer thereof, (S)-(+)-3-(aminomethyl)-5-methyl-hexanoic acid (2). | 2010-12-23 |
20100324140 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES - The present invention discloses novel compounds of Formula I, or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like. | 2010-12-23 |
20100324141 | HIGH PURITY 2-[4-(3- OR 2-FLUOROBENZYLOXY)BENZYLAMINO]PROPANAMIDES AND METHODS OF USE THEREOF - A process for obtaining therapeutically active 2-[4-(3- and 2-(fluorobenzyloxy)benzylamino]-propanamides and their salts with pharmaceutically acceptable acids with a high degree of purity, i.e. with a content of dibenzyl derivatives impurities lower than 0.03% by weight. The process is carried out by submitting a Schiff base intermediate to a reduction reaction with a reducing agent in an amount of organic solvent to allow the formation (and presence during a substantial portion of the reduction reaction) of a suspension of the Schiff base. | 2010-12-23 |
20100324142 | HYDROCORTISONE DERIVATIVES AND USE THEREOF FOR THERAPEUTIC OR COSMETIC INDICATIONS - The present invention relates to hydrocortisone derivatives, the method of production thereof and the therapeutic or cosmetic use thereof to combat hair loss or in the treatment of cutaneous physiopathologies. | 2010-12-23 |
20100324143 | BIS(THIO-HYDRAZIDE AMIDE) SALTS FOR TREATMENT OF CANCERS - Disclosed are bis(thio-hydrazide amide) disalts, which are represented by Structural Formula (I): | 2010-12-23 |
20100324144 | THERAPY FOR HYPEREXCITABILITY DISORDERS - The present invention is directed to the use of a class of peptide compounds for treating diseases associated with hyperexcitability. The present invention is also directed to the use of a class of peptide compounds for treating diseases associated with dysfunction of an ion channel. | 2010-12-23 |
20100324145 | Crystalline ACAT Inhibitor - The invention is directed to the Form A polymorph of N-benzyl-N′-(2,6-diisopropyl-phenyl)-N-isopropyl-malonamide and its use as a therapeutic/cosmetic agent. | 2010-12-23 |
20100324146 | Dendrimeric Enzyme Inhibitors - The present invention relates generally to the use of dendrimer compounds bearing anionic surface groups as inhibitors of hyaluronidase and their use in the treatment of diseases and conditions in which excessive, abnormal or unwanted levels of hyaluronidase are involved or implicated, or in the treatment of diseases or conditions in which the presence or administration of hyaluronic acid is therapeutically effective. The present invention also relates to pharmaceutical compositions and methods for the treatment of such diseases and conditions. | 2010-12-23 |
20100324147 | ARYLCYCLOPROPYLAMINES AND METHODS OF USE - Described herein are arylcyclopropylamine compounds that may inhibit enzymes comprising an amine oxidase domain, such as LSD1, MAO A and/or MAO B. | 2010-12-23 |
20100324148 | VITAMIN K FOR PREVENTION AND TREATMENT OF SKIN RASH SECONDARY TO ANTI-EGFR THERAPY - The invention provides methods and compositions for treating and preventing a skin rash secondary to anti-epidermal growth factor receptor (EGFR) therapy, where the method comprises applying a vitamin K analog or a phosphatase inhibitor to the skin. | 2010-12-23 |
20100324149 | Methods And Compositions For Prevention And Treatment Of Inflammatory Disease, Autoimmune Disease, and Transplant Rejection - The invention provides compositions and methods for reducing one or more symptoms of an autoimmune disease, inflammatory disease, and/or transplant rejection, by the administration to a subject in need thereof a pharmaceutically effective amount of a purified compound of any one of Formulae A-E. The invention's methods are useful for the prevention, amelioration, and treatment of autoimmune disease, inflammatory disease, and/or transplant rejection. | 2010-12-23 |
20100324150 | HYPERBRANCHED POLYGLYCEROL FOR IMPROVING HEART FUNCTION - A method of improving heart function in a subject, the method comprising administering an effective amount of a hyperbranched polyglycerol to a subject. The improvement in heart function may include one or more of an increase in myocardial contractile function, reduced or absent fibrosis, an increase in mechanical efficiency of the heart, an increase in ejection fraction, an increase in glucose oxidation or a decrease in fatty acid oxidation, as determined by conventional methods known in the art. | 2010-12-23 |
20100324151 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFECTION OR INFECTIOUS COLONIZATION OF THE EYELID, OCULAR SURFACE, SKIN OR EAR - The instant invention provides methods and compositions for the treatment of infection or infectious colonization of the eyelid and/or ocular surface for the treatment and prevention of ocular disorders and eyelid disorders. | 2010-12-23 |
20100324152 | USE OF 1,2-DECANEDIOL FOR SEBUM REDUCTION AND COSMETIC AND/OR DERMATOLOGICAL FORMULATIONS COMPRISING 1,2-DECANEDIOL - The present invention relates to a use of 1,2-decanediol for reduction of the sebum concentration of the skin, a cosmetic and/or dermatological formulation for topical application comprising 1,2-decanediol, a method for reduction of the sebum concentration of the skin and a use of 1,2-decanediol and a method for assisting the penetration of one, two, three, four or more active compounds into areas of the skin with increased sebum production. | 2010-12-23 |
20100324153 | ANIONIC ISOSORBIDE DERIVATIVES AND THEIR USE - Disclosed are isosorbide derivatives according to the following general formula | 2010-12-23 |
20100324154 | ASSESSING SUSCEPTIBILITY TO VASCULAR DISORDERS - The invention provides methods and reagents for determination of risk and treatment of a vascular disorder such as abdominal aortic aneurysm (AAA) by detecting presence of gene polymorphisms and/or genetic profiles associated with an elevated or a reduced risk of the disorder. In an embodiment, the present invention provides methods and reagents for determining sequence variants in the genome of an individual which facilitate assessment of risk for developing such diseases. | 2010-12-23 |
20100324155 | PREPARATION OF INORGANIC FOAM - A solution of soluble metal, soluble polymer, and a suitable solvent is converted into a gel body having a surface area to volume ratio no greater than 10. The gel body is converted to inorganic foam. Foams of metal oxide, metal nitride foam, metal carbide foam, metal selenide, and elemental metal were prepared. Several of the foams are (a) molybdenum carbide and molybdenum nitride, (b) TiO, (c) copper selenide, (d) copper indium selenide, (e) molybdenum carbide, molybdenum nitride, and platinum, and (f) ruthenium dioxide. | 2010-12-23 |
20100324156 | METHODS OF RECYCLING CARBON DIOXIDE TO THE GASIFICATION SYSTEM - Method of producing syngas in an IGCC system, comprising compressing and heating carbon dioxide-rich gas to produce heated compressed carbon dioxide-rich gas, mixing the heated compressed carbon dioxide-rich gas with oxygen and feedstock to form a feedstock mixture, subjecting the feedstock mixture to gasification to produce syngas, cooling the syngas in a radiant syngas cooler, contacting syngas cooled in the radiant syngas cooler with compressed carbon dioxide-rich gas to further cool the syngas, and removing an amount of carbon dioxide-rich gas from the product mixture and compressing the removed carbon dioxide-rich gas prior to mixing with oxygen and feedstock. | 2010-12-23 |
20100324157 | HIGH THROUGHPUT FISCHER-TROPSCH CATALYTIC PROCESS DEVELOPMENT METHOD - A method for determining a set of operating parameters for developing a commercial-scale Fischer-Tropsch catalytic plug flow process comprising the steps of: selectively feeding fresh feed gas to the inlet the first laboratory scale plug flow reactor stage of a composite multi-stage series-connected reactor, said reactant feed gas including CO and H | 2010-12-23 |
20100324158 | Catalytic Reactor - A reactor module for Fischer-Tropsch synthesis having a generally rectangular reactor block with a stack of plates defining flow channels for coolant and flow channels for the synthesis reaction arranged alternately in the block. The synthesis flow channels extend in a generally vertical direction between upper and lower faces of the reactor block and are defined by plates in combination with either bars or sheets such that each channel is of width no more than 200 mm. The coolant flow channels are oriented in the same direction, and communicate through distributor chambers with inlet and outlet ports at side faces of the reactor block. A plant may contain a multiplicity of such reactor modules operating in parallel, the modules being interchangeable and replaceable. The temperature control is enhanced by allowing the coolant flow to be parallel to the synthesis gas flow. | 2010-12-23 |
20100324159 | NOVEL ION EXCHANGE POROUS RESINS FOR SOLID PHASE EXTRACTION AND CHROMATOGRAPHY - Embodiments of the present invention are directed to porous resins for solid phase extractions. The resins feature at least one hydrophobic component, at least one hydrophilic component and at least one ion exchange functional group. The resins exhibit superior wetting and ion exchange performance. | 2010-12-23 |
20100324160 | Composite Containing Modified Hybride Resin Based on Natural Fatty Acids - The invention relates to natural fatty acid based hybride resin, modified with reactive monomers, and to a method for preparing it. The invention also relates to the use of the modified natural fatty acid based hybride resin as binding agent especially in water based coatings, glues and composites, and as environmentally friendly wood impregnating agent. The modified natural fatty acid based hybride resin comprises the condensation product of natural fatty acid or natural fatty acid ester, modified with di- or oligo-carboxylic acid or anhydride or half ester, and natural fatty acid based alkyd resin. | 2010-12-23 |
20100324161 | Thermoplastic Vulcanizates and Processes for Making the Same - A process for producing thermoplastic vulcanizates, the process comprising (i) dynamically vulcanizing a rubber with a curative in a first stage, where the rubber is within a blend that includes the rubber, a thermoplastic resin, and the curative, where said step of dynamically vulcanizing occurs at a temperature at or above the melting point of the thermoplastic resin, where said step of dynamically vulcanizing employs a peroxide curative, and where said rubber includes polymeric units deriving from 5-vinyl-2-norbornene, (ii) continuing said step of dynamically vulcanizing to cause phase inversion of the blend to thereby convert the thermoplastic resin into a continuous phase, (iii) maintaining the blend at or above the melting point of the thermoplastic resin after the phase inversion, and (iv) introducing molten thermoplastic resin into the blend in a second stage, where said step of introducing molten thermoplastic resin occurs after phase inversion but before the blend is cooled to a temperature below the melting point of the thermoplastic resin. | 2010-12-23 |
20100324162 | FOAM BOARD OF POLYOLEFIN RESIN AND METHOD FOR ITS PRODUCTION - To provide a foam board of a polyolefin resin which has an excellent heat insulating property and sound absorption property, of which a product can be material-recycled and which can continuously be produced at a low cost. | 2010-12-23 |
20100324163 | ACTIVE ENERGY RAY CURABLE LIQUID COMPOSITION AND LIQUID CARTRIDGE - The invention provides an active energy ray curable liquid composition containing a compound having a bonding group represented by a general formula (I), and a liquid cartridge. | 2010-12-23 |
20100324164 | PHOTOCURABLE RESIN COMPOSITION AND OPTICAL COMPONENT USING THE SAME - The present invention relates to a photocurable resin composition including the following ingredients (A), (B) and (C): (A) a linear chain epoxy resin represented by the following general formula (1), in which m indicates an integer of from 2 to 10, and R | 2010-12-23 |
20100324165 | Ophthalmological Composition And Use Thereof - The subject matter of the present invention is an ophthalmologic composition having an UV absorber and a violet absorber, wherein a high transmission is achieved in the blue light spectrum, and an eye implant, in particular an intraocular lens, which is produced with this ophthalmologic composition. | 2010-12-23 |
20100324166 | USING DISPERSION POLYMERS WITH NONIONIC CHARACTERISTICS AND FORMULATIONS TO REDUCE FRICTION - This invention discloses, compositions of aqueous fluids comprising one or more dispersion polymer(s), wherein the dispersion polymer comprises 96 to 100 mole percent of one or more nonionic monomer units and 0 to 4 mole percent of one or more cationic or anionic monomer units; and has a molecular weight of at least 100,000. The invention also discloses the method(s) of using one or more such dispersion polymer(s), comprising adding to or mixing with the aqueous fluid a friction-reducing amount of the polymer(s), before, during or after a turbulent flow is induced. Nonionic dispersion polymers consistently render substantially greater extents of friction reduction than their ionic counterparts. A dispersion polymer (formed by dispersion polymerization) provides up to four times as much friction reduction as the same polymer in solution when used at the same dosage. Moreover, unlike ionic dispersion polymers, nonionic dispersion polymers are intrinsically compatible with charged oilfield species such as multi-valence brine(s), quaternary amine-based corrosion inhibitors and biocides. | 2010-12-23 |
20100324167 | ONE-POT SYNTHESIS OF NANOPARTICLES AND LIQUID POLYMER FOR RUBBER APPLICATIONS - A method for performing a one-pot synthesis of a blend of nanoparticles and liquid polymer includes polymerizing a first monomer and optionally a second monomer in a hydrocarbon solvent to form the liquid polymer. The polymerization is terminated before completion with a quenching agent. Then a charge of polymerization initiator, and a mixture of cross-linking agent and mono-vinyl aromatic monomer are added. This causes further polymerization whereby nanoparticles are formed having a core including the cross-linking agent, and a shell including the first monomer or the first monomer and the second monomer. Nanoparticle/liquid polymer blends resulting from the method and rubber compositions incorporating the blends are also disclosed. | 2010-12-23 |
20100324168 | TIRE TREAD-USE RUBBER COMPOSITION - A tire tread-use rubber composition includes from 10 to 50 parts by weight of a tackifying resin having a softening point of from 100° C. to 150° C.; from 70 to 130 parts by weight of a carbon black having a nitrogen specific surface area of from 250 to 400 m | 2010-12-23 |
20100324169 | AQUEOUS COATING COMPOSITION HAVING REDUCED PLATE OUT - Fast hardening aqueous latexes and coating compositions, including paints such as traffic paints, comprising a triazole exhibit less plate out onto process metal surfaces compared to similar triazole-free compositions. | 2010-12-23 |
20100324170 | MICROCAPSULE-TYPE LATENT CURING AGENT - An aluminum chelate-based latent curing agent having excellent latency and thermal response includes a latent curing agent in which an aluminum chelating agent is retained in a porous resin obtained by interfacial polymerization of a polyfunctional isocyanate compound, and an enzyme-treated gelatin film coating such latent curing agent. This microcapsule-type latent curing agent can be produced by dissolving an aluminum chelating agent and a polyfunctional isocyanate compound in a volatile organic solvent, charging the obtained solution into a gelatin-containing aqueous phase, carrying out interfacial polymerization by heating and stirring, and subjecting the gelatin to an enzyme treatment by adding an enzyme to the obtained polymerization reaction mixture. | 2010-12-23 |
20100324171 | Thermoplastic compositions containing microspheres - A composition including a poly(biphenylether sulfone) and microparticles. A composition including a poly(aryl ether sulfone), a polyetherimide and/or a polycarbonate, and high crush strength glass hollow microspheres having a crush strength greater than 15,000 psi. Articles made from the compositions. Aircrafts, cars and other vehicles comprising compounds made from the compositions. | 2010-12-23 |
20100324172 | GOLF BALL MATERIAL, GOLF BALL, AND METHOD FOR PREPARING GOLF BALL MATERIAL - The invention provides a golf ball material comprising components (A), (B) and (C): (A) a mixture of different masterbatches prepared by separately masterbatching two or more different metal ions (A1) or a masterbatch prepared by simultaneously masterbatching two or more different metal ions in itself (A2), (B) one or more polymer selected from the group consisting of diene polymers, thermoplastic polymers and thermoset polymers, and (C) one or more polymer having an acid content of from about 0.5 to about 30 wt % and selected from the group consisting of olefin-unsaturated carboxylic acid copolymers, olefin-unsaturated carboxylic acid-unsaturated carboxylic acid ester terpolymers, unsaturated carboxylic anhydride-containing polymers, unsaturated dicarboxylic acid-containing polymers and unsaturated dicarboxylic acid half ester-containing polymers. The invention also provides a method for preparing such a golf ball material, and a golf ball made of the material. The golf ball material has a good thermal stability, flow and processability, making it suitable for injection-molding. Moreover, this material is ideal for producing, without any loss of the rebound resilience of golf ball parts molded from the material, high-performance golf balls having excellent durability, scuff resistance and flexibility. | 2010-12-23 |
20100324173 | AQUEOUS DISPERSIONS OF SILICA FOR INCREASING EARLY STRENGTH IN CEMENTITIOUS PREPARATIONS - Dispersion which is free of binders and which contains silica and at least one superplasticizer, the silica being a precipitated silica having a surface area greater than 50 m | 2010-12-23 |
20100324174 | THERMOPLASTIC RESIN COMPOSITION AND SHAPED ARTICLE THEREFROM - Disclosed are a thermoplastic resin composition which has a reduced tendency to mold staining while being shaped and a high flowability, and a shaped article which, when used as a lamp component, has good surface appearance and generates little volatiles by the heat of the lamp. Specifically disclosed are a thermoplastic resin composition containing a polyester resin (A), a cresol novolac epoxy resin (B), and a vinyl cyanide-aromatic vinyl copolymer containing epoxy group (C), and a shaped article shaped therefrom, wherein the cresol novolac epoxy resin (B) and the vinyl cyanide-aromatic vinyl copolymer containing epoxy group (C) are compounded in amounts of 0.01 to 3 parts by mass and 2 to 12 parts by mass, respectively, relative to 100 parts by mass of the polyester resin (A). | 2010-12-23 |
20100324175 | Polymer for Ultra-High Strength Concrete Admixture and Method for Preparing the Same - Disclosed are a polymer for ultra-high strength concrete admixture and a method for preparing the same, more specifically, a polymer for ultra-high strength concrete admixture prepared by polymerizing two or more copolymers based on unsaturated organic monomers having urethane derivatives, and and a method for preparing the same. Also, the concrete admixture comprising the polymer exhibits high water-reducing ability, thus improving workability and strength of the concrete composition. In addition, the concrete admixture exhibits defoaming capability, thus enabling easy control of air amount of the concrete composition without using any defoaming agent. | 2010-12-23 |
20100324176 | BIODEGRADABLE COMPOSITE SYSTEM AND THE USE THEREOF - The invention relates to a composite system comprising at least one biodegradable blend, containing at least one biodegradable block copolyester urethane (PEU) and also at least one polyhydroxyalkanoate (PHA), possibly a filler comprising a polysaccharide and/or derivatives thereof and also possibly further biocompatible additives. Composite systems of this type are used for producing moulded articles, moulded parts or extrudates. Furthermore, the invention relates to possibilities for using the composite system. | 2010-12-23 |
20100324177 | COLORANT COMPATIBLE HYDROPHOBICALLY MODIFIED POLYETHYLENEGLYCOL THICKENER FOR PAINT - A synthetic polymer has a water-soluble or water-swellable polyethyleneglycol backbone and terminal groups and/or intermediate groups of blocks of hydrophobes of alkyl- or aryl compounds containing a polymerizable cyclic monomer or a polymerizable double bond (or alkene) group or derivatives thereof. The blocks of hydrophobes are composed of two or more units of the same or different hydrophobes. These synthetic polymers are used as rheology modifiers, especially in latex paints. | 2010-12-23 |
20100324178 | FINELY DIVIDED, STARCH-CONTAINING POLYMER DISPERSIONS - Finely divided starch-containing polymer dispersions which are obtainable by free radical emulsion copolymerization of ethylenically unsaturated monomers in the presence of a redox initiator and an enzymatically degraded starch, the enzymatic starch degradation being stopped by adding an acid comprising at least one phosphorus atom to the reaction mixture, use of an acid comprising at least one phosphorus atom for stopping the enzymatic degradation of starch and use of the finely divided, starch-containing polymer dispersions of emulsion polymers as size for paper and paper products, in particular as surface size. | 2010-12-23 |
20100324179 | MODIFIED ASPHALT BINDERS AND ASPHALT PAVING COMPOSITIONS - A process for preparing a modified asphalt binder composition, the process comprising mixing asphalt, an unsaturated polymer, and an organothionating agent to form a modified asphalt composition. | 2010-12-23 |
20100324180 | Pre-Fiber Gel Compositions and Materials, Methods of Manufacture and Uses Thereof - A pre-fiber gel material is described herein that includes: a) at least one amide-based and/or polyamide-based composition; and b) at least one lactam gelling agent, wherein the gel composition has sufficient viscosity and sufficient cohesiveness upon the mixing of the at least one amide-based or polyamide-based polymer and the at least one lactam gelling agent that the composition can be spun into a fiber. In addition, methods are provided herein that teach that the production of a pre-fiber gel composition, including: a) providing at least one amide-based compound; b) providing at least one lactam gelling agent; and c) mixing the at least one amide-based polymer and the at least one lactam gelling agent such that there is sufficient viscosity and to sufficient cohesiveness in the composition so that it can be spun into a fiber. | 2010-12-23 |
20100324181 | ULTRAVIOLET ABSORBER COMPOSITION AND RESIN COMPOSITION - An ultraviolet absorber composition is provided and includes: a compound represented by formula (I); and an ultraviolet absorber having a maximum absorption at a wavelength of from 340 to 400 nm: | 2010-12-23 |
20100324182 | FLAME RETARDANT COMPOSITIONS COMPRISING STERICALLY HINDERED AMINES - The present invention relates to a novel method of flame retarding a polymeric substrate by adding a small but efficient amount of a synergistic mixture of at least one sterically hindered N-alkoxyamine (NOR), at least a metal salt of hypophosphorous (phosphinic) acid and at least one organo-halogen flame retardant. A further aspect of the invention is the flame retardant composition itself and together with a polymer. The present invention also relates to polymeric articles (e.g. moldings, films, fibers, etc.) that are stabilized against light, heat and oxygen and made flame retardant by incorporation of at least one sterically hindered N-alkoxy amine, at least a metal salt of hypophosphorous acid (phosphinic acid) and at least one organo-halogen flame retardant. | 2010-12-23 |
20100324183 | HALOGEN-FREE FLAME-RETARDANT TPU - The present invention relates to a flame-retardant mixture comprising
| 2010-12-23 |
20100324184 | COATED POLYOXYMETHYLENES - The present invention relates to coated polyoxymethylene moldings comprising at least one polyoxymethylene homo- or copolymer A), and also, if appropriate, further additives B), which has been coated on the surface with at least one binder C) and one formaldehyde scavenger D), wherein the binder C) used comprises a polyalkylene oxide C | 2010-12-23 |
20100324185 | EPOXIDIZED SOYATE DIESTERS AND METHODS OF USING SAME - An unhindered polyol is used to react with an epoxidized soyate to make epoxidized soyate diester in the presence of a catalyst. The unhindered polyol can be 1,3-propanediol or any polyol having four or more carbon atoms with no two adjacent carbon atoms having hydroxyl functionality. Preferably, a combination of catalysts is used to promote the transesterification reaction of the epoxidized soyate with the unhindered polyol to yield a high percentage of epoxidized soyate diester with epoxy functionality retained. The primary catalyst is a metallic hydroxide, and the secondary catalyst is a titanate. Bioderived epoxidized soyate diester plasticizers useful for thermoplastics and thermosets result. | 2010-12-23 |
20100324186 | PREPARATION OF ORGANIC ADDITIVE-TREATED, PYROGENIC SILICA-ENCAPSULATED TITANIUM DIOXIDE PARTICLES - One aspect of the invention is to provide a composition comprising a titanium dioxide particle having on the surface of said particle a substantially encapsulating layer comprising a pyrogenically-deposited metal oxide; said substantially encapsulating layer having on its surface at least one organic surface treatment material selected from an organo-silane, an organo-siloxane, a fluoro-silane, an organo-phosphonate, an organo-acid phosphate, an organo-pyrophosphate, an organo-polyphosphate, an organo-metaphosphate, an organo-phosphinate, an organo-sulfonic compound, a hydrocarbon-based carboxylic acid, an associated ester of a hydrocarbon-based carboxylic acid, a derivative of a hydrocarbon-based carboxylic acid, a hydrocarbon-based amide, a low molecular weight hydrocarbon wax, a low molecular weight polyolefin, a co-polymer of a low molecular weight polyolefin, a hydrocarbon-based polyol, a derivative of a hydrocarbon-based polyol, an alkanolamine, a derivative of an alkanolamine, an organic dispersing agent, or a mixture thereof. Another aspect of the invention is to provide processes for producing said composition. | 2010-12-23 |
20100324187 | Silicone Resin Composites for High Temperature Durable Elastic Composite Applications and Methods for Fabricating Same - This invention relates to composites for use in high temperature elastic composite applications. Most particularly, this invention relates to elastic composites formed with a silanol-silanol condensation reaction mixture of silsesquioxane silicone resins thermally stabilized by boron nitride, silica and boron oxide additives as their matrix. The polymer matrix composite comprise a matrix of cured high, intermediate and optionally low molecular weight silicone resins including boron nitride and silica additives and reinforcing material. | 2010-12-23 |
20100324188 | Fiber Reinforced Nylon Composition - The present invention relates to a fiber reinforced nylon composition, wherein the composition includes (A) 25 to 75 parts by weight of a polyarylamide resin, (B) 25 to 75 parts by weight of a reinforcing fiber having a cross-sectional aspect ratio of 1.5 or more, and (C) an impact modifier, and the impact modifier is included in an amount of 1 to 10 parts by weight based on 100 parts by weight of a mixture of the polyarylamide resin and the reinforced fiber. According to the present invention, the fiber reinforced nylonresin composition may exhibit minimal or no warpage, can have excellent fluidity and impact resistance, and can provide high whiteness and a glossy-coating due to minimal or no surface change after dipping in boiling water. | 2010-12-23 |
20100324189 | SYSTEM FOR COMPRISING AT LEAST ONE EXTRUDED OR INJECTION MOULDED PART, METHOD FOR THE PRODUCTION THEREOF AND USE OF THE SAME - The invention relates to a system ( | 2010-12-23 |
20100324190 | POWDERY COMPOSITION OF A POLYMER AND A FLAMEPROOFING AGENT CONTAINING AMMONIUM POLYPHOSPHATE, METHOD FOR THE PRODUCTION THEREOF, AND MOULDED BODY PRODUCED FROM SAID POWDER - A pulverulent composition that is a powder containing at least one polymer, and at least one flame retardant that contains ammonium polyphosphate, the powder having a maximum particle size of ≦150 μm and a median particle size of from 20 to 100 μm. | 2010-12-23 |
20100324191 | COMPOSITES OF POLYMERS AND METAL/METALLOID OXIDE NANOPARTICLES AND METHODS FOR FORMING THESE COMPOSITES - Successful dispersion approaches are described for the formation of dispersion of dry powders of inorganic particles. In some embodiments, it is desirable to form the dispersion in two processing steps in which the particles are surface modified in the second processing step. Composites can be formed using the well dispersed particles to form improved inorganic particle-polymer composites. These composites are suitable for optical applications and for forming transparent films, which can have a relatively high index or refraction. In some embodiments, water can be used to alter the surface chemistry of metal oxide particles. | 2010-12-23 |
20100324192 | Method for the Production of Flameproofed Fiber Composite Materials or Prepregs - The invention relates to an optimized method for improving the flameproofing of fiber composite materials or prepregs, particularly for the production of thermosets. An upper limit already exists on the percentage increase in flameproofing agent for glass fiber composites. However, the application of natural fibers in the composite increases the demands placed on the flameproofing. Thus the problem addressed by this invention is to offer a new method for the flameproofing of natural fiber composites and composites with increased flameproofing, and for the flameproofing of conventional fiber composites, which avoids the disadvantages of known methods which are created by increasing the viscosity of the polymer with flameproofing agent. Furthermore, a flameproofed composite should be offered, which avoids the disadvantages of known fiber composites which are created by increasing the viscosity of the polymer with flameproofing agent. The problem is solved, in addition to a device according to the invention, in that during the production of flameproofed fiber composite materials containing fiber material embedded in polymer, a cover layer is constructed containing flameproofing agent in the area of at least one surface area of the fiber composite materials. | 2010-12-23 |
20100324193 | A PROCESS FOR THE PRODUCTION OF NANODISPERSIBLE BOEHMITE AND THE USE THEREOF IN FLAME RETARDANT SYNTHETIC RESINS - The present invention relates to processes for the production of at least partially pepetizable and at least partially peptized boehmite particles, the at least partially pepetizable and at least partially peptized boehmite particles, and the use of the at least partially peptized boehmite particles to flame retard synthetic resins. | 2010-12-23 |
20100324194 | Composite Material and Method of Producing the Same, and Composite Metal Material and Method of Producing the Same - A method of producing a composite material which includes a carbon-based material and a particulate or fibrous metal material Z. The method includes steps (a) to (c). In the step (a), at least a first carbon material and the metal material Z mixed into an elastomer, and dispersing the first carbon material and the metal material Z by applying a shear force to obtain a composite elastomer, the metal material Z having a melting point lower than a melting point of the first carbon material. In the step (b), the composite elastomer is heat-treated to vaporize the elastomer to obtain an intermediate composite material including a second carbon material and the metal material Z. In the step (c), the intermediate composite material is heat-treated together with a substance including an element Y having a melting point lower than the melting point of the metal material Z to vaporize the substance including the element Y. | 2010-12-23 |
20100324195 | Nanocomposite compositions of polyamides and Sepiolite-type clays - The invention is directed to nanocomposite compositions that contain at least one thermoplastic polyamide and unmodified sepiolite-type clay nanoparticles. It, also, includes articles containing such compositions. | 2010-12-23 |
20100324196 | PROCESS FOR MAKING STRAIN-HARDENED POLYMER PRODUCTS - A process which subjects a body of polymer to deformation to produce strain hardened polymeric products including blending a polymer and a nanoparticle material to produce a polymeric composition, forming a film from the polymeric composition, and subjecting the composition to strain hardening. The resulting product has improved clarity, dimensional stability, uniform thickness, due to the “self-leveling” properties of the polymeric composition. | 2010-12-23 |
20100324197 | ORGANO-NEUTRALIZED CALCINED KAOLINS FOR USE IN SILICONE RUBBER-BASED FORMULATIONS - Disclosed herein are organo-neutralized calcined kaolins comprising calcined kaolin treated with at least one basic organic compound, a composition comprising the organo-neutralized calcined, and use of the organo-neutralized calcined kaolin in silicone rubber formulations. Further disclosed herein are a method of making the organo-neutralized calcined kaolin and a method of making a silicone rubber formulation comprising the organo-neutralized calcined kaolin. | 2010-12-23 |
20100324198 | DISPERSION STABILIZER FOR SUSPENSION POLYMERIZATION OF VINYL COMPOUND AND METHOD OF PRODUCING VINYL COMPOUND POLYMER - Provided is a polyvinyl alcohol-based dispersion stabilizer used for suspension polymerization of a vinyl compound. When this dispersion stabilizer is used, it reduces the formation of coarse particles and allows the obtained vinyl polymer to have a sharp particle size distribution, and reduces the amount of scale deposited on a polymerization vessel more than ever before. Also provided is a method of producing this dispersion stabilizer. This dispersion stabilizer is composed of a carbon monoxide-vinyl alcohol copolymer including a constitutional unit derived from carbon monoxide (a CO unit) and a vinyl alcohol unit, and has a content of the CO unit of 0.01 to 8 mol %, a viscosity-average degree of polymerization of 200 to 3500, and a saponification degree of 60 to 90 mol %. | 2010-12-23 |
20100324199 | WATERBORNE URETHANE-BASED TWO-COAT COATING SYSTEMS, USE THEREOF AND SUBSTRATES COATED WITH THEM - The present invention relates to an aqueous clearcoat material for producing a waterborne urethane-based two-coat coating system, which comprises at least one secondary polyacrylate dispersion having a polyacrylate glass transition temperature T | 2010-12-23 |
20100324200 | Rubber Composition in Particular for the Manufacture of Tires - A rubber composition, in particular intended for the manufacture of tires, based on at least a predominant elastomer, chosen from the group consisting of butyl rubbers, essentially unsaturated diene elastomers, essentially saturated diene elastomers and the mixtures of these elastomers, and a reinforcing filler, characterized in that the composition also comprises graphite and a functionalized or nonfunctionalized polyisobutylene oil, having a molecular weight of between 200 g/mol and 40 000 g/mol, present in a proportion of between 2 and 50 phe. | 2010-12-23 |